These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 33046271)

  • 21. Clear cell papillary renal cell carcinoma: Incidence, morphological features, immunohistochemical profile, and biologic behavior: A single institution study.
    Alexiev BA; Drachenberg CB
    Pathol Res Pract; 2014 Apr; 210(4):234-41. PubMed ID: 24485757
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An epidemiological and clinicopathological study of type 1 vs. type 2 morphological subtypes of papillary renal cell carcinoma- results from a nation-wide study covering 50 years in Iceland.
    Runarsson TG; Bergmann A; Erlingsdottir G; Petursdottir V; Heitmann LA; Johannesson A; Asbjornsson V; Axelsson T; Hilmarsson R; Gudbjartsson T
    BMC Urol; 2024 May; 24(1):105. PubMed ID: 38741053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clear Cell Papillary Renal Cell Carcinoma.
    Zhao J; Eyzaguirre E
    Arch Pathol Lab Med; 2019 Sep; 143(9):1154-1158. PubMed ID: 30672334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Update on selected renal cell tumors with clear cell features. With emphasis on multilocular cystic clear cell renal cell carcinoma.
    Montironi R; Mazzucchelli R; Scarpelli M; Lopez-Beltran A; Cheng L
    Histol Histopathol; 2013 Dec; 28(12):1555-66. PubMed ID: 23893851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clear cell papillary renal cell carcinoma, renal angiomyoadenomatous tumor, and renal cell carcinoma with leiomyomatous stroma relationship of 3 types of renal tumors: a review.
    Hes O; Compérat EM; Rioux-Leclercq N
    Ann Diagn Pathol; 2016 Apr; 21():59-64. PubMed ID: 26897641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel molecular signature identifies mixed subtypes in renal cell carcinoma with poor prognosis and independent response to immunotherapy.
    Büttner FA; Winter S; Stühler V; Rausch S; Hennenlotter J; Füssel S; Zastrow S; Meinhardt M; Toma M; Jerónimo C; Henrique R; Miranda-Gonçalves V; Kröger N; Ribback S; Hartmann A; Agaimy A; Stöhr C; Polifka I; Fend F; Scharpf M; Comperat E; Wasinger G; Moch H; Stenzl A; Gerlinger M; Bedke J; Schwab M; Schaeffeler E
    Genome Med; 2022 Sep; 14(1):105. PubMed ID: 36109798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clear-cell papillary renal cell tumour: New insights into clinicopathological features and molecular landscape after renaming by 5th WHO classification.
    Zhang W; Zhang L; Wen Z; Liang J; Wang Y; Wang Z; Yin Z; Fan L
    Pathol Res Pract; 2024 Mar; 255():155167. PubMed ID: 38324963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of histologic subtype and sarcomatoid transformation on metastasis in renal cell carcinoma: a single institute experience in 149 patients.
    Tirumani SH; Souza D; Krajewski KM; Jagannathan JP; Ramaiya NH; Shinagare AB
    Abdom Radiol (NY); 2016 Feb; 41(2):295-302. PubMed ID: 26867911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clear cell papillary renal cell carcinoma - An indolent subtype of renal tumor.
    Chen WJ; Pan CC; Shen SH; Chung HJ; Lin CC; Lin ATL; Chang YH
    J Chin Med Assoc; 2018 Oct; 81(10):878-883. PubMed ID: 30037497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Probability of Aggressive Versus Indolent Histology Based on Renal Tumor Size: Implications for Surveillance and Treatment.
    Bhindi B; Thompson RH; Lohse CM; Mason RJ; Frank I; Costello BA; Potretzke AM; Hartman RP; Potretzke TA; Boorjian SA; Cheville JC; Leibovich BC
    Eur Urol; 2018 Oct; 74(4):489-497. PubMed ID: 30017400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrated Phenotypic/Genotypic Analysis of Papillary Renal Cell Carcinoma Subtypes: Identification of Prognostic Markers, Cancer-related Pathways, and Implications for Therapy.
    Saleeb RM; Plant P; Tawedrous E; Krizova A; Brimo F; Evans AJ; Wala SJ; Bartlett J; Ding Q; Boles D; Rotando F; Farag M; Yousef GM
    Eur Urol Focus; 2018 Sep; 4(5):740-748. PubMed ID: 28753789
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Do clear cell papillary renal cell carcinomas have malignant potential? Diolombi ML, Cheng L, Argani P, Epstein JI.Am J Surg Pathol. December 2015;39(12):1621-1634.
    Kryvenko ON
    Urol Oncol; 2017 Jun; 35(6):451-452. PubMed ID: 28416105
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of papillary and clear cell renal cell carcinoma through imaging mass cytometry reveals distinct immunologic profiles.
    Govindarajan A; Salgia NJ; Li H; Castro DV; Mirzapoiazova T; Armstrong B; Zhao D; Mercier BD; Dizman N; Chawla N; Zengin Z; Meza L; Tripathi N; Sayegh N; Chehrazi-Raffle A; Tripathi A; Pal SK
    Front Immunol; 2023; 14():1182581. PubMed ID: 37638025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clear cell papillary renal cell carcinoma with angiomyomatous stroma: a histological, immunohistochemical, and fluorescence in situ hybridization study.
    Alexiev BA; Thomas C; Zou YS
    Virchows Arch; 2014 Jun; 464(6):709-16. PubMed ID: 24771120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Papillary renal neoplasm with reverse polarity-a comparative study with CCPRCC, OPRCC, and PRCC1.
    Wang T; Ding X; Huang X; Ye J; Li H; Cao S; Gao Y; Ma X; Huang Q; Wang B
    Hum Pathol; 2022 Nov; 129():60-70. PubMed ID: 35977593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of clinicopathologic predictors of oncologic outcome provides insight into the natural history of surgically managed papillary renal cell carcinoma.
    Margulis V; Tamboli P; Matin SF; Swanson DA; Wood CG
    Cancer; 2008 Apr; 112(7):1480-8. PubMed ID: 18240184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histologic subtype needs to be considered after partial nephrectomy in patients with pathologic T1a renal cell carcinoma: papillary vs. clear cell renal cell carcinoma.
    Yoo S; You D; Jeong IG; Song C; Hong B; Hong JH; Ahn H; Kim CS
    J Cancer Res Clin Oncol; 2017 Sep; 143(9):1845-1851. PubMed ID: 28451753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Papillary (chromophil) renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 62 cases.
    Amin MB; Corless CL; Renshaw AA; Tickoo SK; Kubus J; Schultz DS
    Am J Surg Pathol; 1997 Jun; 21(6):621-35. PubMed ID: 9199639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Succinate dehydrogenase B: a new prognostic biomarker in clear cell renal cell carcinoma.
    Cornejo KM; Lu M; Yang P; Wu S; Cai C; Zhong WD; Olumi A; Young RH; Wu CL
    Hum Pathol; 2015 Jun; 46(6):820-6. PubMed ID: 25827535
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of Clinical Cases of Advanced Papillary Renal Cell Carcinoma via Comprehensive Genomic Profiling.
    Pal SK; Ali SM; Yakirevich E; Geynisman DM; Karam JA; Elvin JA; Frampton GM; Huang X; Lin DI; Rosenzweig M; Lipson D; Stephens PJ; Ross JS; Miller VA; Agarwal N; Shuch B; Choueiri TK; Chung JH
    Eur Urol; 2018 Jan; 73(1):71-78. PubMed ID: 28592388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.